Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (421-430 of 560) with videos related to

Pageof 56
Sort By:
JAMA Network Open|November 2, 2021
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Breast Cancer Research and Treatment|May 2, 2012
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studyLawrence J Solin, Robert Gray, Lori J Goldstein, et al.
BMJ Supportive & Palliative Care|November 14, 2019
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic reviewFrancesco Sparano, Neil K Aaronson, Mirjam A G Sprangers, et al.
Seminars in Oncology|February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancerNicholas J Robert, Charles L Vogel, I Craig Henderson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
JCO Oncology Practice|January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care SystemFrancesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
British Journal of Haematology|April 11, 2016
Central nervous system involvement in AIDS-related lymphomasStefan K Barta, Jitesh Joshi, Nicolas Mounier, et al.
Seminars in Oncology|February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trialsDavid S Alberts, Franco M Muggia, James Carmichael, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.
Pageof 56

Showing results (421-430 of 560) with videos related to

Sort By:
Pageof 56
JAMA Network Open|November 2, 2021
Patient-Reported Testing Burden of Breast Magnetic Resonance Imaging Among Women With Ductal Carcinoma In Situ: An Ancillary Study of the ECOG-ACRIN Cancer Research Group (E4112)Soudabeh Fazeli, Bradley S Snyder, Ilana F Gareen, et al.
Breast Cancer Research and Treatment|May 2, 2012
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 studyLawrence J Solin, Robert Gray, Lori J Goldstein, et al.
BMJ Supportive & Palliative Care|November 14, 2019
Inclusion of older patients with cancer in randomised controlled trials with patient-reported outcomes: a systematic reviewFrancesco Sparano, Neil K Aaronson, Mirjam A G Sprangers, et al.
Seminars in Oncology|February 19, 2005
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancerNicholas J Robert, Charles L Vogel, I Craig Henderson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Deep Learning on Histopathological Images to Predict Breast Cancer Recurrence Risk and Chemotherapy BenefitGil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
JCO Oncology Practice|January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care SystemFrancesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
British Journal of Haematology|April 11, 2016
Central nervous system involvement in AIDS-related lymphomasStefan K Barta, Jitesh Joshi, Nicolas Mounier, et al.
Seminars in Oncology|February 19, 2005
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trialsDavid S Alberts, Franco M Muggia, James Carmichael, et al.
Breast Cancer Research and Treatment|September 27, 2013
Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinomaEleni Andreopoulou, Ivette S Vigoda, Vicente Valero, et al.
Breast Cancer Research and Treatment|December 28, 2011
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivoB Ramaswamy, W Fiskus, B Cohen, et al.
Pageof 56